JOHN BOURAS: Open Payments
NPI 1669514311 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$604 in 17 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $47 · 2025 $604
Food & beverage: $604
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $209 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $130 |
| Otsuka America Pharmaceutical, Inc. | 5 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $18 |
Products named: SPRAVATO, CAPLYTA, Qelbree, REXULTI, TRINTELLIX, ABILIFY ASIMTUFII, AUSTEDO XR, FANAPT.
Industry payments across TX — which companies pay providers there.
